Nav: Home

ACP receives four-year federal award to increase adult immunization rates

September 15, 2015

The American College of Physicians (ACP) was awarded a $1,002,884 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) to increase immunization rates in the United States. The award enables ACP to expand its seven-state evidence-based program to increase adult vaccination rates, which was funded by the CDC for 2013-15.

"Appropriate immunization of adults is a core component of preventive health care, leading to improved public health, fewer deaths, less suffering, and lower health care costs," said Wayne J. Riley, MD, MACP, president, ACP. "This award will help ACP's internal medicine physician members and their practice teams to protect their patients from serious, painful, and life-threatening diseases such as influenza, pneumococcal disease, shingles, whooping cough, measles, and others."

Fully funded by the CDC, this ACP national immunization initiative will expand its 2013-15 program piloted in partnership with state ACP chapters in Arizona, Delaware, District of Columbia, Idaho, Illinois, Maryland, New Mexico, and New York. In those states, ACP assisted 381 physicians in implementing strategies for improving adult immunization rates toward the federal government's goals for 2020, including seasonal influenza immunization rates of 80 to 90 percent of adults, depending on risk factors. The most recent data show only 42 percent of adults receives this vaccine.

Results from ACP's pilot program include increasing immunization rates for herpes zoster by 14.3 percent, high risk pneumococcal by 23.5 percent, influenza by 18.3 percent (and 25 percent for health care personnel), and Tdap by 14.7 percent.

ACP endorses the annual Advisory Committee on Immunization Practices (ACIP) Adult Immunization Schedule and advises adults to get immunized for seasonal flu and to use that opportunity to discuss with their internist other vaccinations they might need. These include Tdap to protect against tetanus; diphtheria, and pertussis (whooping cough); pneumococcal to protect against pneumonia, bacteremia, and meningitis; HPV to prevent cervical, anal, and other cancers; Hepatitis B; and herpes zoster to help prevent shingles.

"Many adults are unaware of the benefits of vaccines, the need for booster doses, and the availability of newer vaccines," Dr. Riley said. "Every year in the United States, hundreds of thousands of adults get sick, miss work, or die because of vaccine-preventable diseases or their complications. That's why ACP supports eliminating existing exemptions, except for medical reasons, from immunization laws. Allowing exemptions based on non-medical reasons poses a risk both to the unvaccinated person and to public health."
-end-
About the American College of Physicians

The American College of Physicians is the largest medical specialty organization and the second-largest physician group in the United States. ACP members include 143,000 internal medicine physicians (internists), related subspecialists, and medical students. Internal medicine physicians are specialists who apply scientific knowledge and clinical expertise to the diagnosis, treatment, and compassionate care of adults across the spectrum from health to complex illness. Follow ACP on Twitter and Facebook.

American College of Physicians

Related Influenza Articles:

How proteins help influenza A bind and slice its way to cells
Researchers have provided new insight on how two proteins help influenza A virus particles fight their way to human cells.
Eating elderberries can help minimize influenza symptoms
Conducted by Professor Fariba Deghani, Dr. Golnoosh Torabian and Dr.
Mechanism to form influenza A virus discovered
A new study by Maria João Amorim's team, from the Gulbenkian Institute of Science, now reveals where the genomes of the influenza A virus are assembled inside infected cells.
Bat influenza viruses could infect humans
Bats don't only carry the deadly Ebola virus, but are also a reservoir for a new type of influenza virus.
New VaxArray publication on influenza neuraminidase quantification
InDevR Inc. announced publication of 'A Neuraminidase Potency Assay for Quantitative Assessment of Neuraminidase in Influenza Vaccines' in npj Vaccines.
More Influenza News and Influenza Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...